Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients

Conditions: Peritoneal Dialysis Complication; Renal Function Aggravated; Sodium-glucose Co-transporter-2 Inhibitors Interventions: Drug: Dapagliflozin Sponsors: Sichuan Academy of Medical Sciences Recruiting

https://clinicaltrials.gov/study/NCT06398977

Source: ClinicalTrials.gov - May 3, 2024 Category: Research Source Type: clinical trials